Brief: Quotient Provides Update On COVID-19 Antibody Test Progress

Quotient

09/06/2020 11:08

June 9 (Reuters) - Quotient Ltd  QTNT.O :
    * QUOTIENT LIMITED PROVIDES UPDATE ON COVID-19 ANTIBODY TEST
PROGRESS, OTHER KEY DEVELOPMENTS AND Q4 AND FULL YEAR FISCAL
2020 RESULTS
    * QUOTIENT LTD - QTRLY TOTAL REVENUE $8.7 MILLION VERSUS
$8.3
MILLION
    * QUOTIENT LTD - QTRLY LOSS PER SHARE $0.31
    * QUOTIENT LTD SEES 2021 TOTAL PRODUCT SALES OF ALBA BY
QUOTIENT
REAGENTS IN RANGE OF $32 TO $34 MILLION
    * QUOTIENT LTD - DEVELOPED COVID-19 ANTIBODY TEST
    * QUOTIENT LTD - SEVERAL CUSTOMER CONTRACTS SIGNED FOR
MOSAIQ
SYSTEM AND COVID-19 ANTIBODY TEST

Source text for Eikon:  ID:nGNX4Qj7pZ 
Further company coverage:  QTNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))